Metabolic mechanism and pharmacological study of albendazole in secondary hepatic alveolar echinococcosis (HAE) model rats
作者:Chaoqun Li、Yaogang zhang、Mingquan Pang、Yong Zhang、Chunhui Hu、Haining Fan
DOI:10.1128/aac.01449-23
日期:2024.5.2
Alveolar echinococcosis (AE) is a zoonotic parasitic disease resulting from human infection by the larval stage of the alveolar tapeworm, Echinococcus multilocularis. This larval stage originates in the liver and possesses exogenous and invasive growth characteristics, infecting the entire liver over the course of 5–10 years, similar to a tumor. This leads to it sometimes being referred to as “worm
肺泡包虫病 (AE) 是一种人畜共患寄生虫病,由人类感染肺泡绦虫(多房棘球绦虫)的幼虫阶段引起。该幼虫阶段起源于肝脏,具有外源性和侵袭性生长特征,在5-10年的时间内感染整个肝脏,类似于肿瘤。这导致它有时被称为“蠕虫癌”。此外,它可以转移和扩散,引起其他器官的继发性病变,如果不治疗或治疗不彻底,死亡率很高(1, 2)。该病主要分布于中亚、东欧、北美等畜牧业发达地区,呈现局部流行趋势。中国约占全球感染病例的 91%,青海、新疆、西藏和四川的患病率很高,影响了农业社区的健康和经济发展 (3, 4)。